Objective:
(Addict Disord Their Treatment 2015;14:139-151) C annabis and tobacco frequently cooccur. 1, 2 Cannabis use promotes the transition to greater tobacco use, 3 and tobacco use is a key precursor to cannabis relapse. 4 Further, cousers tend to believe that they are more addicted to nicotine 5 and are less likely to quit smoking cigarettes relative to those who do not use cannabis. 6, 7 Thus, efforts to better understand underlying mechanisms and cognitive processes are warranted to further inform co-use interventions.
A small but growing body of literature has examined the cross-substance links between cannabis and tobacco. 8, 9 This work has included examinations from a motivational framework, and indicates that among tobacco users, cannabis motives are linked with increased quantity and frequency of cannabis use. 8, 10 Moreover, explorations of individual characteristics show that anxiety sensitivity moderates the effect of enhancement motives on cannabis use among daily smokers. 8 Further, specific cannabis motives have been linked with use: coping motives are associated with negative emotional symptoms, whereas enhancement motives are linked with positive affect 11 and with the use of alcohol and tobacco. 9 Thus, cannabis motives contributed unique variance to noncannabis substance use including nicotine dependence and the number of cigarettes smoked per day. 9 Taken together, the cross-substance literature indicate that substance use and reasons thereof can influence the use of and other substances. Although some work has shown cross-substance links with respect to motivation, additional work is needed to better understand the impact of motives not only on cognitively based factors important to quit processes, but also the impact on actual success in quitting. Recent work in this arena has shown that nontreatmentseeking cannabis smokers have motives similar to cigarette smokers who later quit without formal treatment. 12 Although this work evinced relations among motives and quit success in a convenience sample, 12 there still exists a gap in knowledge with respect to quit success among treatment-seeking samples, and as such, further examination is needed.
CURRENT STUDY
The present research was designed to address this gap in the literature by better elucidating the impact of cannabis motives on cognitive factors associated with quitting tobacco and success in quitting tobacco use. We specifically sought to examine if latent variables representing each of the 5 cannabis motives subscales (social, enhancement, coping, conformity, and expansion), and a general latent cannabis motives variable (comprised of all five subscales), would evince predictive validity with respect to tobacco-related barriers, expectancies, and quit success. Our hypothesis was that cannabis motives would be associated with tobacco outcomes such that having more reasons to use cannabis (eg, reporting more motives) would be linked with more barriers to cessation, stronger smoking expectancies (eg, desiring to control appetite/weight via cigarettes), and difficulty quitting (eg, lower quit success). Structural equation modeling (SEM) was used to test this hypothesis, based on its strengths to account for measurement errors of the observed variables by modeling them as latent constructs. 13 Further, a bifactor model of cannabis motives was examined to determine whether this approach might best elucidate the relations between cannabis motives and smoking consequences. The benefit of this approach, in which common variance among cannabis motives is separated from variance specific to a particular motive, is that the effects of each specific motive can be examined independent of overall desire to use cannabis. 14, 15 
METHODS

Participants
The sample consisted of 403 daily smokers who responded to advertisements about a smoking cessation treatment study. As shown in Table 1 , the sample was primarily male (n = 214, 53%), with a mean age of 35.24 years (SD = 13.45). Participants were mainly white/Caucasian (n = 324, 85%) and had never married (n = 181, 47%). Of the sample, 46% met criteria for at least 1 current axis I diagnosis, and the most common diagnoses were social phobia (11%), generalized anxiety disorder (5%), alcohol abuse (3%), and alcohol dependence (3%). Most of the sample reported having started smoking cigarettes before the age of 18 (n = 322, 80%). Under half of the sample reported r10 years of being a regular daily cigarette smoker (n = 160, 40%), and the other half of the sample reported smoking cigarettes daily for either r20 years (n = 77, 19%), r30 years (n = 72, 18%), r40 years (n = 61, 15%), ror 50 years (n = 12, 3%). Participants reported the number of cigarettes smoked when smoking the heaviest as under 10 (n = 22, 5%), under 20 (n = 86, 21%), under 30 (n = 49, 12%), under 40 (n = 63, 16%), under 50 (n = 48, 12%), or at least 50 (n = 17, 4%). The majority of the sample reported having started using cannabis before the age of 18 (n = 291, 72%). Most of the respondents indicated being a regular daily cannabis user for r10 years (n = 231, 57%). Of the remaining, 30 participants (7%) indicated using cannabis regularly for r20 years, 17 (4%) endorsed r30 years, and 7 (2%) endorsed r40 years of regular cannabis use.
Measures
Demographics. Participants reported demographic information including sex, age, and race/ethnicity.
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Diagnostic assessments were conducted using the SCID-I-NP Non-Patient Version 16 to assess DSM-IV-TR diagnoses for past and current axis I disorders. 16, 17 All SCID-I interviews were administered by trained research assistants or doctoral-level staff and were supervised by independent doctoral-level professionals. In addition, interviews were audio-taped and the reliability of a random selection of 12.5% of interviews were reviewed for accuracy (M.J.Z.); no cases of diagnostic coding disagreement were noted.
Motives for Cannabis Use. The Marijuana Motives Questionnaire (MMQ) was used to assess reasons or motives for using cannabis. 18, 19 The MMQ is comprised of 25 items and has shown high levels of internal consistency for each of the 5 factors. 20 Respondents rated items on a 5-point scale ranging from 1 (Never/Almost Never) to 5 (Almost Always/Always 21 is a 50-item measure that assesses tobacco outcome expectancies believed to underlie smoking motivation on a Likert-type scale, ranging from 0 (Completely Unlikely) to 9 (Completely Likely). The 4 constituent factors of the SCQ are: (1) negative consequences (perceived unpleasantness of smoking effects; a = 0.88); (2) positive reinforcement-sensory satisfaction (positive emotional states; a = 0.87); (3) negative reinforcementnegative affect reduction (negative emotional states, a = 0.94); and (4) appetiteweight control (desired outcome of controlling weight; a = 0.91). The SCQ has demonstrated adequate psychometric properties and predictive validity, 22 and the subscales demonstrated high levels of internal consistency in the current sample (all a's>0.80).
Barriers to Smoking Cessation. The Barriers to Cessation Scale (BCS) assesses barriers or specific stressors associated with smoking cessation. 23 The BCS consists of 19 items on which respondents indicate, on a 4-point Likert-style scale (0 = ''Not A Barrier'' to 3 = ''Large Barrier''), the extent to which they identify with each of the listed barriers to cessation. Good internal consistency has been reported, as has good content and predictive validity. 23, 24 Three subscales reflect different types of stressors associated with quitting smoking: (1) addictive barriers (withdrawal symptoms of feeling lost without cigarettes; a = 89); (2) external barriers (triggers or encouragement from friends; a = 75); and (3) internal barriers (emotions or feeling in control of moods; a = 74). Positive and Negative Symptoms. The Positive Affect Negative Affect Schedule (PANAS) is a 20-item, trait-like measure of positive and negative affect. 25 Mood descriptors, such as ''Nervous'' or ''Excited,'' were rated on a 5-point Likert-style scale, with instructions to rate ''to what extent you generally feel this way, that is, how you feel on average.'' Both 10-item positive and negative affect subscales have demonstrated good psychometric properties, 26 strong internal consistency, and test-retest reliability. 25 The PANAS negative affect scale was used for the present study, with higher scores reflecting greater self-reported negative affectivity (a = 0.92 in the current sample).
Quit Status. Smoking cessation was assessed 2 weeks after baseline. The quit status variable was dummy coded such that participants with carbon monoxide (CO) levels of r4 ppm at week 2 were categorized as quitters and received a 1. Those with CO levels >4 ppm at week 2 were categorized as nonquitters and received a 0. 27 Cigarette Smoking History. The Smoking History Questionnaire, 28 a 31-item measure, was used to assess smoking rate, age of onset of initiation, years of being a daily smoker, and other characteristics. 28 Smoking rate was obtained from the open-ended question, ''Since you started regular daily smoking, what is the average number of cigarettes you smoked per day?'' Cannabis Use History. Cannabis use was assessed using the 40-item Marijuana Smoking History Questionnaire (MSHQ). The MSHQ assesses history and patterns of cannabis use. 29 Example items include ''How many years have you smoked marijuana?'' and ''Think about your smoking during the last week, how much marijuana did you smoke per occasion in an average day?'' Participants rated the latter item on an 8-point Likert scale. Scores correspond to pictures depicting increasing sizes of cannabis joints, with 1 indicating the smallest cannabis joint and 8 indicating the largest cannabis joint. Previous research has used the MSHQ as a successful indicator of cannabis use. 30 Alcohol Use. Alcohol consumption was assessed using the Alcohol Use Disorders Identification Test (AUDIT), a 10-item measure that screens for harmful or hazardous drinking. 31 Items include quantity and frequency of drinking, heavy consumption, tolerance, dependence, and alcohol problems. The AUDIT has demonstrated good psychometric properties. 32 The AUDIT's internal consistency a was.85 in the present sample, and in past work it has reliably distinguished between harmful, hazardous, and no drinking histories. 31, 33 For example, a score of 8 on the AUDIT produces 85% sensitivity and 89% specificity for hazardous or harmful drinking. 34 Medical History. The current research team developed the Medical Screening Questionnaire to assess medical history. Items of interest for the present study involved those specific to substance-use disease in which participants indicated having ever been diagnosed with the following (0 = no, 1 = yes): heart problems, hypertension, respiratory disease, and asthma. As in past work, 35 a composite score for health problems was created from this measure, ranging from 0 to 4, with greater scores reflecting the occurrence of multiple markers of tobacco-related disease.
Procedure
Participants included in the present analyses were daily smokers recruited to a larger study via community-based advertisements including radio announcements, newspaper ads, and flyers. The larger study examined efficacy of a standard smoking cessation program and novel 4-session smoking cessation behavioral intervention focused on vulnerability to panic (Panic-Smoking Program). Data for the present analyses came from the baseline assessment and 2-week follow-up of the larger trial. Participants were scheduled for an in-person baseline assessment during which they provided written informed consent and were evaluated according to inclusion and exclusion criteria. Participants were then interviewed using the SCID and completed a battery of self-reported measures. CO was assessed during follow-up. This study was approved by the institutional review boards at Florida State University and the University of Vermont.
Data Analytic Procedure
Zero-order correlations and univariate statistics were first computed for all relevant variables. Confirmatory factor analysis (CFA) in Mplus version 7 36 was then used to examine the measurement model of the Cannabis Motives Factors (ie, Social, Coping, Enhance, Conform, and Expansion Motives). Two models were compared, a correlated factors model, in which Cannabis Motives Factors were created using item-level data and were allowed to correlate freely across factors. However, because prior studies have shown a high degree of overlap among the factors, which can result in multicollinearity when using cannabis motives jointly as predictors, another model, in which common variance, attributable to all items, formed a common Cannabis Motives Factor, and variance attributable only to the cluster of items associated with each cannabis motives scale, formed specific, orthogonal factors.
Cannabis motive items were treated as categorical and the default robust weighted least squares estimator was used (WLSMV in Mplus). Models were scaled by fixing the variance of the factors to 1. The correlated factors model was compared with the bifactor model using the DIFFTEST option in Mplus. A nonsignificant value indicated that the bifactor model did not improve upon model fit of the correlated factors model. Overall model fit was examined using the w 2 statistic with a nonsignificant value indicating good model fit. However, the w 2 statistic may be too restrictive, especially with larger sample sizes and many items per factor. [37] [38] [39] Therefore, the comparative fit index (CFI), and the root mean square error of approximation (RMSEA) were also used to provide additional model fit information. CFI values >0.90 and RMSEA values <0.08 indicate adequate fit and CFI values >0.95 and RMSEA values <0.05 indicate good fit. 40 Confidence intervals (CIs) for the RMSEA were also employed, with a lower bound CI containing 0.05 indicating that good fit cannot be rejected and an upper bound CI containing 0.10 indicating that poor fit cannot be rejected.
Once the best-fitting model of cannabis motives was selected, SEMs were conducted to examine the concurrent relations between cannabis motives and (1) the BCS factors (ie, BCS Addiction, BCS External, and BCS Internal); and (2) the SCQ scales (ie, SCQ Negative Consequences, SCQ Positive Reinforcement, SCQ Negative Reinforcement, and SCQ Appetite/Weight Control), separately. The SCQ variables were treated as scales because a CFA indicated that these scales did not form distinct latent factors. Control variables included smoking rate (as measured by SHQ item 4), AUDIT total score, PANAS NA, health problems, and sex (females coded as 0, males as 1). Items for the BCS were treated as categorical. Finally, an SEM was conducted to examine the effects of the cannabis motives on smoking cessation at week 2 (0 = did not quit smoking, 1 = quit smoking), including all prior control variables as well as treatment condition (1 = active, 2 = control).
RESULTS
Descriptive Statistics and Correlations
Descriptive statistics and correlations for all relevant predictor, control, and outcome variables are provided in Table 2 
CFA of Cannabis Motives
Structural Equation Models of the Relations Between Cannabis Motives and Smoking Variables
The SEM including the General Cannabis Motives Factor, the specific Cannabis Motives Factors, and the control variables predicting the BCS Addiction, BCS External, and BCS Internal factors provided adequate fit to the data ( 
Structural Equation Model Examining the Effects of the Cannabis Motives on Quit Status Following a Smoking Intervention
The SEM including the specific and General Cannabis Motives Factors and the control variables (including treatment condition) predicting quit status at week 2 provided adequate fit to the data (w 2 = 698.39, df = 403, P<0.05, CFI = 0.98, RMSEA = 0.07 [95% CI, 0.06-0.07]). Model parameters (in probit regression coefficients) are provided in Table 5 . The only significant predictors of week 2 quit status were the Coping Motives Factor (B probit = -0.42, P<0.01), which was negatively associated with having quit, and the Conformity Motives Factor (B probit = 0.24, P<0.05), which was positively associated with having quit. At mean levels of all predictors, the probability of having quit smoking at week 2 was 53.2%. The probability of having quit smoking at week 2 was 68.4% at 1 SD below the mean levels of Coping Motives and only 35.9% at 1 SD above the mean levels of Coping Motives. The probability of having quit smoking at week 2 was 42.9% at 1 SD below the mean levels of Conformity Motives and 61.8% at 1 SD above the mean levels of Conformity Motives.
DISCUSSION
The present research examined relationships among cannabis motives, barriers to cessation, smoking consequences, and follow-up quit status were examined in a sample of daily cigarette smokers. Our hypothesis was that cannabis motives would be associated with more barriers to cessation, stronger smoking expectancies, and greater difficulty quitting over and above theoretically relevant variables. Results supported these expectations and showed that cannabis motives were associated with subscales of the BCS. Specifically, coping motives were associated with reduced barriers related to tobacco addiction, fewer negative smoking expectancies, and decreased positive reinforcement with respect to smoking. Conformity motives were associated with fewer internal smoking barriers. Expansion motives were associated with reporting more positive reinforcement related to smoking. The general motives variable, comprised of variance common to all cannabis motives, was associated with reporting more barriers related to tobacco addiction, having more external barriers, reporting greater positive reinforcement consequences, and more negative expectancies. Taken together, these findings lend support to the cross-substance perspective that motives for using 1 substance (cannabis) influence cognitive factors important to quitting another (tobacco).
Results from a bifactor model supported predictions in that significant relationships emerged between motives and quit factors. When examining quit status at week 2 in the bifactor model, 2 significant relationships emerged, the first being between conformity motives and quit status, and the second being between coping motives and quit status. Conformity motives positively predicted the probability of having quit smoking at week 2, whereas coping motives negatively predicted quit status. In other words, individuals who used cannabis for conformity reasons were more likely to successfully quit smoking; however, individuals who used cannabis for coping reasons were less likely to quit smoking. It is possible that relative to those who use cannabis for coping reasons, those who use cannabis for conformity reasons are less likely to turn to cannabis during times of stress or to relieve tension or anxiety. Extant literature supports this view, and suggests that individuals who use cannabis for coping reasons may represent a population vulnerable to cannabis misuse and problems. 41, 42 To our knowledge, the current study is the first to examine the factor structure of cannabis motives using bifactor modeling. 14, 15 An important benefit of SEM is the ability to model latent variables with reduced measurement error. Despite this, many studies involving the relations between MMQ subscales and external variables are conducted using regression-based techniques. 43, 44 One barrier might be the increased likelihood of multicollinearity when conducting SEM as compared with SEM, due to the reduction in measurement error. Results from a simulation study indicate that in instances of high multicollinearity (ie, correlations between factors >0.80), the likelihood of producing improper solutions (ie, inaccurate parameter estimates and standard error estimates as well as type II errors) was likely. 45 Even in instances of more moderate multicollinearity (ie, correlations between factors from 0.60 to 0.80) there was still a >50% chance of type II errors, especially when reliability is low and the effects are small. Although not reported, most of the correlations between MMQ factors exceeded 0.60 (7 of 10) and one even exceeded the 0.80 threshold. Therefore, results of the present analyses indicate that researchers interested in examining MMQ subscales using SEM would likely benefit from separating cannabis motives into a general motivation to use cannabis factor orthogonal to more specific motivations for using cannabis to examine specificity of each of the cannabis motives.
Limitations
The strengths of the present work must be considered in light of its limitations. First, regarding the present data, results indicate short-term impact (2 wk) of cannabis motives on smoking cessation. Although this is an improvement on cross-sectional designs, additional work is needed to understand whether motives for cannabis use have more distal impacts on quitting tobacco. Thus, further research is needed to evaluate the behavioral significance of these results and assess clinical benefit versus cost of implementing interventions or programs designed to target cannabis motives. Second, the relatively homogeneous demographic composition of the present sample may limit generalizability of findings to other racial/ethnic or age groups. Also related to generalizability, the present sample was comprised of adult smokers who volunteered for a smoking cessation intervention, and as such, additional work is needed to understand whether findings extend to populations that are not treatment-seeking. Third, we oriented the present work on an a priori basis on the role of cannabis motives in terms of smoking processes and behavior. However, explorations of the role of smoking motives on cannabis processes and behavior are warranted. Finally, key variables were assessed via self-report, and thus, there is the possibility that observed relations were in part a function of shared method variance.
CONCLUSIONS
The present study was designed to examine the impact of cannabis motives on cognitively based factors important to quitting tobacco use. In particular, we examined effects of latent cannabis motives variables on tobacco-related barriers and expectancies, and success in quitting. Results supported expectations that significant relationships would emerge; however, closer examinations revealed that cannabis motives subscales were not uniformly predictive of quit success. Additional work is needed to better understand underlying mechanisms and potential points of intervention. 
